Immunol Res (2018) 66:71022
CrossRef Effectiveness of therapeutic strategies based on dietary patterns on cardiovascular and hepatic markers in individuals with metabolic dysfunction-associated steatotic liver disease (MASLD) A systematic review of clinical trials Valeria Antonia Rivera Marn, Camila Sanchez, Andrea Herrera-Santelices, Luisa Amanda Ramrez Araya, Edson Yez-Barros, Sebastian Cofr Nutricin Hospitalaria .2026;[Epub] CrossRef Extracellular Vesicle from Chlorella vulgaris Alleviates Hepatic Fibrosis in a Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease Through Modulation of Inflammatory Signaling Hinata Harada, Yusuke Ohsaki, Afifah Zahra Agista, Hsin-Jung Ho, Takuo Hirose, Kotaro Yamada, Mutsumi Furukawa, Tomonori Nochi, Wan-Chun Chiu, Ya-Ling Chen, Chiu-Li Yeh, Suh-Ching Yang, Takefumi Mori, Hitoshi Shirakawa International Journal of Molecular Sciences .2026

Due to the high cost of the branded GLP-1 drugs, which can top more than $1k a month without insurance coverage, new options have emerged for consumers, including direct-to-consumer access to compounded versions of these medications
Fras JP, Davies MJ, Rosenstock J, Prez Manghi FC, Fernndez Land L, Bergman BK, Liu B, Cui X, Brown K, for the SURPASS-2 Investigators